UH Cancer Center partners with nation’s top cancer centers to endorse goal
Nearly 80 million Americans – one out of every four people – are infected with human papillomavirus (HPV). And of those millions, more than 31,000 will be diagnosed with an HPV-related cancer this year. Despite those staggering figures and the availability of a vaccine to prevent the infections that cause these cancers, HPV vaccination remains low in the U.S.
University of Hawai'i Cancer Center has partnered with 69 other National Cancer Institute (NCI)-designated cancer centers to issue a statement urging for increased HPV vaccination and screening to eliminate HPV-related cancers, starting with cervical cancer. These institutions collectively recognize insufficient vaccination as a public health threat and call upon the nations' physicians, parents and young adults to take advantage of this rare opportunity to eliminate several different types of cancer in men and women.
As a part of this initiative, the UH Cancer conducted a statewide survey of primary care physicians who identified specific barriers to adolescent HPV vaccine uptake. The barriers identified were related to logistics, attitudes and perceptions, as well as the absence of school-based HPV vaccine requirements.
"HPV vaccination remains a powerful tool in the effort to prevent cancers caused by the human papillomavirus in Hawai'i. The need for HPV vaccination is underscored by the steady increase in certain HPV-associated cancers including anal cancers in Hawai'i and the U.S. overall," said Brenda Hernandez, PhD, UH Cancer Center epidemiologist and senior author of the Hawai'i study published in the Journal of Community Health.
"Preventing cancer is a central mission of the UH Cancer Center. We are honored to join our other National Cancer Institute-Designated Cancer Center colleagues and cancer prevention organizations in recommending this Call to Action to reduce the burden of HPV-related cancers," said Randall Holcombe, MD, MBA, UH Cancer Center director.
"We have the opportunity to eliminate multiple HPV-related cancers beginning with cervical cancer. To accomplish this goal, we need to utilize our most important tool – HPV vaccination," said Anna R. Giuliano, PhD, director of the Center for Infection Research in Cancer at Moffitt Cancer Center. "We are asking health care providers to stand with us and recommend the HPV vaccine. Parents can join with us by asking their doctors about vaccination."
Vaccination rates remain significantly lower than other recommended adolescent vaccines in the U.S. According 2016 data from the Centers for Disease Control (CDC), less than 50 percent of girls and 38 percent of boys completed the recommended vaccine series. Research shows there are a number of barriers to overcome to improve vaccination rates, including a lack of strong recommendations from physicians and parents not understanding that this vaccine protects against several types of cancer in men and women. HPV causes multiple cancers including cervical, anal, oropharyngeal (middle throat) and other genital cancers.
HPV experts from the nation's top cancer centers, along with partners from the NCI, CDC, and the American Cancer Society, are meeting June 7-8 in Salt Lake City to discuss a path forward to eliminating cancers caused by HPV, including ways to reduce barriers to vaccination, as well as share education, training and intervention strategies to improve vaccination rates.
"The United States has an unprecedented opportunity to not just prevent cancers caused by HPV but to eliminate them. This means getting to a point in time when cancers such as cervical cancer are no longer diagnosed in our country," said Giuliano.
This is the third year that all NCI-designated cancer centers have come together to issue a national call to action. All 70 cancer centers unanimously share the goal of sending a powerful message to parents, adolescents and health care providers about the importance of HPV vaccination for the elimination of HPV-related cancers.
The University of Hawai'i Cancer Center through its various activities, cancer trial patients and their guests, and other visitors adds more than $54 million to the O'ahu economy. It is one of only 70 research institutions designated by the National Cancer Institute. Affiliated with the University of Hawai'i at Mānoa, the Center is dedicated to eliminating cancer through research, education, patient care and community outreach with an emphasis on the unique ethnic, cultural, and environmental characteristics of Hawai'i and the Pacific. Learn more at http://www.uhcancercenter.org. Like us on Facebook at http://www.facebook.com/UHCancerCenter. Follow us on Twitter @UHCancerCenter.